What Microlut Treats: Main Uses and Benefits

Microlut is commonly used within therapeutic areas involving fertility management and patient health needs where estrogen is medically restricted. Its application is relevant in managing symptomatic concerns related to the avoidance of pregnancy, excessive menstrual bleeding, and cyclical uterine discomfort.

The primary purpose of the medication is to provide scheduled birth control and prevention of pregnancy. This is a relevant option for patient groups for whom estrogen is restricted, such as women with certain cardiovascular concerns, a history of vascular events, or specific types of migraine, and may assist with maintaining functional stability in these symptomatic contexts. Furthermore, it is a relevant option for hormonal contraception in the postpartum phase for women who are actively breastfeeding.

“The progestogen-only composition provides a supportive therapeutic benefit, offering assistance when avoiding estrogen is a medical necessity.”

Beyond contraception, it is used in situations involving patterns of heavy menstrual bleeding and associated cyclical uterine discomfort, supporting the patient during difficult episodes by easing distress.

---

Quick Fact: Support for Menstrual Symptom Management Microlut may be part of symptomatic management during periods of excessive blood loss and painful cramping, assisting with maintaining functional stability.

Microlut (levonorgestrel 30mu g) is a progestogen-only contraceptive pill (POP) and is contraindicated for use in specific populations as defined by regulatory documents.

Populations Who Must Not Use Microlut (Contraindications)

Contraindicated Condition/Status	Eligibility Classification
Known or suspected pregnancy	Absolute exclusion
Active or past thromboembolic disorders (e.g., DVT, PE, stroke, myocardial infarction)	Absolute exclusion
Severe hepatic disease (until liver function is normal) or hepatic tumors	Absolute exclusion
Known or suspected sex hormone-dependent malignancies (e.g., breast cancer)	Absolute exclusion
Undiagnosed vaginal bleeding	Absolute exclusion
Known hypersensitivity to levonorgestrel or any excipients	Absolute exclusion

Special Eligibility Rules

Microlut is not intended for use in women who are pre-menarcheal (before their first period) or who are postmenopausal.

Pregnancy and Lactation: Use is prohibited during pregnancy. The product is frequently used in breastfeeding women, as it minimally affects milk supply, though small amounts of the drug are known to pass into breast milk.

Interactions with other medicines and products

Some medicines may interfere with the effectiveness of Microlut, potentially reducing protection against pregnancy. Conversely, Microlut may also affect the action of other medicines. Patients must inform their healthcare provider of all prescription and non-prescription medicines, supplements, or herbal products they are taking.

Products that may affect Microlut

The following categories and specific medicines are known to have clinically significant interactions, primarily due to enzyme-inducing properties which may reduce the concentration of the active substance (levonorgestrel):

Product Category	Examples of Interacting Medicines
Tuberculosis treatments	Rifampicin, Rifabutin
Epilepsy (Anticonvulsants)	Phenytoin, Primidone, Barbiturates, Carbamazepine, Topiramate, Lamotrigine
HIV/HCV treatments	Ritonavir, Nevirapine, Boceprevir, Telaprevir
Antifungals	Griseofulvin, Ketoconazole
Antibiotics	Penicillins, Tetracycline, Macrolides (e.g., Erythromycin)
Herbal Medicine	St John's Wort

Other Notable Interactions

• Cyclosporin: Microlut may affect the way the immunosuppressant cyclosporin works.
• Diabetes Medication: For women with diabetes, the required dose of anti-diabetic medication may need to be adjusted, as Microlut can have a slight effect on peripheral insulin resistance and glucose tolerance.
• Blood Tests: Microlut may interfere with the results of certain blood tests. The laboratory staff should be informed if you are taking this medicine.

Required Precautions

If any of the interacting medicines are taken concurrently, additional non-hormonal barrier methods of contraception (such as condoms) must be used. This additional protection is required not only while taking the interfering medicine but also for a period of time after stopping it, as advised by a healthcare professional.

The action of Microlut is governed by its single active ingredient, Levonorgestrel, which functions as an agonist at the Progesterone Receptor (PR). This molecular interaction modifies genetic activity within target reproductive cells, initiating a series of physiological changes focused on creating barriers to conception.

Targeting the Progesterone Receptor

This interaction modulates key physiological processes by influencing steroid hormone signaling patterns.

Peripheral Contraceptive Barriers

By acting on the cervix and endometrium, the mechanism initiates signaling sequences that lead to the thickening of cervical mucus and the structural modification of the uterine lining. These actions create physical local barriers to sperm penetration and implantation.

Modulating the Hormonal Control Axis

Levonorgestrel exerts a systemic negative feedback influence on the Hypothalamic-Pituitary-Ovarian (HPO) axis. This action partially suppresses the release of key hormones, including LH and FSH, engaging mechanisms that regulate the timing of ovarian activity, which may result in **variable suppression of ovulation.***>>

Official Administration Guidelines: Levonorgestrel 30 mug Tablet

Microlut is an oral contraceptive delivered as a coated tablet containing a single active ingredient, 30 mu g Levonorgestrel. The administration protocol is characterized by a precise, continuous daily schedule without any tablet-free interval.

Dosing and Scheduling

The standard regimen is one tablet daily, which represents the maximum recommended dose per 24-hour interval. To maintain consistent efficacy, the tablet must be taken at the same time each day. General instructions emphasize that the interval between two consecutive tablets must not exceed 27 hours (i.e., being more than three hours late). Tablets are swallowed whole with a little liquid, and intake is not dependent on meals (may be taken with or without food).

When one pack of 28 tablets is finished, the next pack is started immediately on the following day, supporting the drug’s long-term continuous use.

Procedural Constraints

Clinical guidelines outline critical rules for managing the start of treatment or missed doses:

Administration Scope	Official Instruction
Starting Use	If initiated later than Day 1 of the menstrual cycle, an additional non-hormonal barrier method must be used for the first seven days of tablet intake.
Missed Dose	If the tablet is taken more than three hours late ( >27 hours elapsed), the missed dose should be taken immediately. An additional barrier method of contraception must be used for the subsequent seven days.

These instructions define the standardized approach to using the medicine, strictly adhering to the continuous daily oral regimen and its associated critical timing requirements.

Microlut is an oral progestogen-only contraceptive (POP), commonly known as the mini-pill. Its active ingredient is levonorgestrel (30 micrograms per tablet). As a POP, it differs from combined oral contraceptives by containing only one hormone and no estrogen.

Efficacy and Mechanism of Action

Clinical research has demonstrated that when used correctly, progestogen-only pills like Microlut are highly effective at preventing pregnancy. Typical-use effectiveness rates are reported to be approximately 93%.

The mechanism of action is primarily achieved through several biological effects, without consistently inhibiting ovulation, unlike combined pills:

Primary Contraceptive Effect	Description
Cervical Mucus Thickening	Makes the mucus at the entrance of the uterus (cervix) thicker, creating a barrier that restricts sperm movement.
Endometrial Changes	Alters the lining of the uterus (endometrium), making it less receptive to the implantation of a fertilized egg.

Safety and Trial Population

Microlut is often a suitable option for individuals who cannot use contraceptives containing estrogen, such as those with a history of certain circulatory conditions or those who are breastfeeding.

Studies have shown that the risk of venous thromboembolism (blood clots) associated with progestogen-only pills is lower than the risk associated with combined hormonal contraceptives and is also lower than the risk of blood clots during pregnancy. Trials and clinical use have informed its application across various adult groups and pediatric populations (post-menarche).

Common questions about Microlut (FAQ)

Q: How quickly does Microlut start working?

Regulatory guidance indicates that if Microlut is started later than the first day of the menstrual cycle, an additional non-hormonal barrier method is required for the first seven days of tablet intake. This necessity reflects the period required for the full contraceptive effects to become established.

Q: What should I do if I miss a Microlut pill?

Official guidance states that if a tablet is taken less than three hours late, the missed pill should be taken immediately and the user should continue with the next pill at the usual time. If the tablet is taken more than three hours late (over 27 hours elapsed), official documents recommend the use of an additional non-hormonal barrier method for the subsequent seven days.

Q: Is it normal to have irregular bleeding when starting Microlut?

Yes, irregular bleeding patterns are classified as a very common side effect of Microlut, potentially affecting 1 or more in 10 users. This may include spotting, infrequent bleeding, or the absence of bleeding (amenorrhea). This pattern is often noted in official documents to be more frequent during the start of treatment.

Q: Are headaches a common side effect of Microlut?

According to official product information, headaches are listed as a common side effect of Microlut, which affects between 1 and 10 in 100 users. Regulatory information notes that individuals experiencing concerning side effects should consult their healthcare provider.

Q: Can Microlut affect my mood or emotional health?

Official regulatory documents classify both mood changes and depressed mood as common side effects of the medicine. These common effects affect up to 10 in 100 users. Regulatory information notes that individuals experiencing concerning side effects should consult their healthcare provider.

Q: Does Microlut cause weight gain for most people?

Weight change or gain is listed in official documents as a common side effect of Microlut. A common side effect affects between 1 and 10 in 100 users.

Q: Can Microlut be taken indefinitely for a long period?

Official administration guidelines describe a continuous daily schedule for Microlut, supporting long-term, continuous use. The long-term appropriateness of the medication is typically assessed during routine healthcare visits.

Q: Does the time of day I take Microlut matter?

Yes, strict timing is emphasized in the official instructions. The tablet must be taken at the same time each day. Official instructions specify that the interval between two consecutive tablets must not exceed 27 hours for efficacy, emphasizing the need for strict timing.

Q: Can Microlut affect the results of blood tests?

Yes, official product information states that Microlut may interfere with the results of certain blood tests. The medicine's label states that laboratory staff should be informed if the patient is taking this medicine.

Q: What is the difference between Microlut and combined pills?

Microlut is classified as a progestogen-only pill (POP), often called the mini-pill, and contains only one active hormone, levonorgestrel. In contrast, combined oral contraceptives contain two types of hormones: a progestin and an estrogen. This single-hormone structure is often cited as an option for individuals who need to avoid estrogen.

Q: Are there any herbal supplements that interact with Microlut?

Yes, official regulatory documents specifically name St John's Wort as a herbal medicine known to have clinically significant interactions with Microlut. These types of interactions may reduce the concentration of the active substance, which can compromise the medicine’s action.

Q: Can women who are breastfeeding use Microlut?

Official documents note that Microlut is frequently used in breastfeeding women. It is described as having only a minimal effect on milk supply, although small amounts of the active drug are known to pass into breast milk.

Q: Is Microlut suitable for women over 35?

The official product constraints specify that Microlut is not intended for postmenopausal women. Consultation with a healthcare provider is necessary to determine individual eligibility and assess overall health factors.

Q: Can taking antibiotics reduce the effectiveness of Microlut?

Regulatory information indicates that several categories of antibiotics are known to interfere with the effectiveness of Microlut. Listed examples include certain Penicillins, Tetracycline, and Macrolides. In such cases, additional non-hormonal barrier methods of contraception may be necessary, as determined by a healthcare provider.

Q: Is vomiting or severe diarrhea a concern regarding pill absorption?

Official warnings indicate that severe gastrointestinal disturbance, such as vomiting or severe diarrhea, may compromise the absorption of the active ingredient. The medicine's label indicates that such an event may compromise absorption, and a healthcare provider should be consulted for specific guidance on contraceptive measures.

Q: What happens if Microlut is stopped suddenly?

Regulatory information indicates that when the mini-pill is stopped, fertility is expected to return to normal within a very short time. The statement implies the end of the drug’s contraceptive effects.

Q: Can Microlut cause acne or breakouts?

Acne is listed in official regulatory documents as a common side effect of the medicine. A common side effect affects between 1 and 10 in 100 users.

Q: How long does it take for fertility to return after stopping Microlut?

Official patient leaflets indicate that fertility is expected to return to normal within a very short time of stopping the mini-pill.

Q: Does Microlut help regulate my cycle?

Microlut is intended solely for contraception. The most frequently observed side effect of the pill is an irregular bleeding pattern, which is the opposite of cycle regulation. This irregularity may include spotting, infrequent bleeding, or the complete absence of bleeding.

Q: Are mood swings a temporary side effect when starting?

Mood changes and depressed mood are classified as common side effects. While regulatory documents note that irregular bleeding is often more frequent at the start of treatment, official product information does not specify a general timeframe for when these other common side effects might subside.

Q: What research evidence exists regarding Microlut?

Clinical research evidence for Microlut, a progestogen-only pill, demonstrates high effectiveness when used correctly. Studies indicate reported typical-use effectiveness rates of approximately 93% at preventing pregnancy.

How to Store and Dispose of Microlut?

Storage Requirements

Microlut tablets must be stored in the original blister pack in a cool, dry place where the ambient temperature stays below 30 C.

Regulatory documents explicitly instruct that the product must be kept out of the reach of children. A high, locked cupboard is cited as a suitable child-safe location. Storage environments that expose the medicine to destructive heat and dampness are prohibited; these include bathrooms, window-sills, or vehicles.

Handling and Disposal

The integrity of the packaging is vital; the tablets must not be taken if the pack is torn or shows signs of tampering. Furthermore, the product must not be used past the expiry date printed on the packaging.

Any unused, expired, or damaged Microlut must be returned to a pharmacist for disposal. This procedure ensures adherence to official pharmaceutical waste handling guidelines.